Ocutec Ltd Secure £1.5M Seed Funding Round
Ocutec, which is part of the Deepbridge Technology Growth EIS portfolio, has recently secured £1.5 million in a seed funding round that was led by Deepbridge Capital.
Ocutec, which is part of the Deepbridge Technology Growth EIS portfolio, has recently secured £1.5 million in a seed funding round that was led by Deepbridge Capital.
Deepbridge Capital has been shortlisted for the Deal of the Year (Transaction size below £2.5 million) Award at the upcoming 2022 Insider Media, Northern Ireland Dealmakers Awards.
One of the world's largest global wealth managers, UBS, has partnered with Fund Her North, working to improve access to finance for female-led businesses.
Fund Her North is made up of over 28 women in venture capital, including Samantha Piddington (Head of Corporate Finance - Deepbridge Capital), funding organisations and angel groups with a combined investment power of over £450m.
Deepbridge has today (19 January 2022) announced that Pathfinder Medical, a portfolio company within the Deepbridge Life Sciences EIS fund has secured a further £8.5 million funding round, led by BGF and Parkwalk.
Deepbridge Capital has deployed over £50 million of capital into UK life sciences companies.
The Deepbridge Life Sciences EIS was launched in 2017 as our first life sciences focused EIS fund, providing private investors with access to a portfolio of early-stage investee companies across the biopharmaceutical, biotechnology, medical technology and digital healthcare sectors.
Fund Her North has facilitated investment into six female led businesses worth over £4.2m in its first year, since it was established in October 2020.
Deepbridge would like to introduce our new EIS Product Overview Brochures; giving you a chance to look at both our EIS propositions, The Deepbridge Technology Growth EIS and The Deepbridge Life Sciences EIS, in a more summarised, yet informative, manner.
As well as outlining the opportunity, investment strategy and key tax benefits of the propositions, example portfolio companies are given to highlight the types of companies that Deepbridge seek to invest in.
Deepbridge would like to introduce our new SEIS Product Overview Brochures; giving you a chance to look at both our SEIS propositions, The Deepbridge Innovation SEIS and The Deepbridge Life Sciences SEIS, in a more summarised, yet informative, manner.